Skip to main content
. 2017 Feb 23;8(19):31435–31448. doi: 10.18632/oncotarget.15634

Table 1B. Characteristics of the included studies (ZEB2).

Study (year) Country Participants Follow-up(month) Age Specimens Method Protein/mRNA Analysis Endpoints Cancer Type Quality Assessment
Cai (2012) China 220/28 (M/F) 26.0 (median) 47.8 (mean) tissue IHC protein multivariabe OS hepatocellular carcinoma 17
Dai (2012) China 50/26 (M/F) 40 (median) 53.8 (mean) tissue IHC protein Univariable OS gastric cancer 14
Kahlert (2011) German 121/54 (M/F) 124 (median) NA tissue IHC protein multivariabe DFS colorectal cancer 14
Kurahara (2012) Japan 52/24 (M/F) NA 67 (median) tissue IHC protein univariable OS pancreatic cancer 13
Okugawa (2013) Japan 106/28 (M/F) 23 (median) 67 (mean) tissue qRT-PCR mRNA multivariabe OS gastric cancer 15
Otsuki (2011) Japan 84/22 (M/F) 48 (median) NA tissue qRT-PCR mRNA univariable DFS, RFS gastric cancer 15
Sun (2015) Chian 192/69 (M/F) 50 (median) 59 (mean) tissue IHC protein univariable OS, DFS gastric cancer 17
Techasen (2014) Thailand 149/66 (M/F) NA 21-82 tissue IHC, qRT-PCR protein, mRNA univariable OS cholangiocarcinoma 13
Xia-cohort I (2014) China 581/109 (M/F) 4-96 51.8 (mean) tissue IHC protein univariable OS hepatocellular carcinoma 15
Xia-cohort II (2014) China 256/56 (M/F) 4-96 51.9 (mean) tissue IHC protein univariable OS hepatocellular carcinoma 15
Yang Z. (2015) China 79/13 (M/F) NA NA tissue IHC protein univariable OS hepatocellular carcinoma 11
Yoshida (2015) Japan 100/11 (M/F) NA 64.3 (mean) tissue IHC protein univariable OS, DFS esophageal squamous cell carcinoma 12
Yoshida (2015) Japan 100/11 (M/F) NA 64.3 (mean) tissue IHC protein univariable OS, DFS esophageal squamous cell carcinoma 12
Yoshida (2015) Japan 100/11 (M/F) NA 64.3 (mean) tissue IHC protein univariable OS, DFS esophageal squamous cell carcinoma 12

M: male; F: female; NA: not available; IHC: immunohistochemistry; qRT-PCR: quantitative real time polymerase chain reaction; OS: overall survival; RFS: recurrence free survival; DFS: disease free survival.